Načítá se...
Cancer Drug Delivery: Considerations in the Rational Design of Nanosized Bioconjugates
[Image: see text] In order to efficiently deliver anticancer agents to tumors, biocompatible nanoparticles or bioconjugates, including antibody–drug conjugates (ADCs), have recently been designed, synthesized, and tested, some even in clinical trials. Controlled delivery can be enhanced by changing...
Uloženo v:
| Vydáno v: | Bioconjug Chem |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Chemical
Society
2014
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4275162/ https://ncbi.nlm.nih.gov/pubmed/25385142 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/bc500481x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|